MPN
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms (NCT05123365) | University of California, Irvine | 2022-01-03 |
| Haplo Peripheral Blood Sct In GVHD Prevention (NCT04473911) | Zachariah Michael DeFilipp | 2020-08-14 |
| Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia (NCT02611973) | Assistance Publique - Hôpitaux de Paris | 2016-03-10 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
Track MPN automatically
Every clearance here is in the API, with alerts when new ones post.